These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 18577437)

  • 1. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entrapment and release difference resulting from hydrogen bonding interactions in niosome.
    Hao YM; Li K
    Int J Pharm; 2011 Jan; 403(1-2):245-53. PubMed ID: 20971171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
    Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
    J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
    Pardakhty A; Varshosaz J; Rouholamini A
    Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of niosomes containing ribavirin for liver targeting.
    Hashim F; El-Ridy M; Nasr M; Abdallah Y
    Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of proniosomes as a drug carrier for flurbiprofen.
    Ibrahim MM; Sammour OA; Hammad MA; Megrab NA
    AAPS PharmSciTech; 2008; 9(3):782-90. PubMed ID: 18587650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of formulation compositions on niosomal preparations.
    Chaw CS; Kim KY
    Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proniosomes as drug carriers.
    Sankar V; Ruckmani K; Durga S; Jailani S
    Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
    Aggarwal D; Garg A; Kaur IP
    J Pharm Pharmacol; 2004 Dec; 56(12):1509-17. PubMed ID: 15563757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
    Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
    Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
    Bendas ER; Abdullah H; El-Komy MH; Kassem MA
    Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics.
    Zidan AS; Mokhtar M
    J Pharm Sci; 2011 Jun; 100(6):2212-21. PubMed ID: 21259237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
    Hasan AA
    Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.